The impact of opiate agonist maintenance therapy on drug use within social networks of injecting drug users

American Journal on Addictions

Volumn 17, Issue 5, 2008, Pages 414-421

  Lloyd, Jacqueline J ^a,f   Strathdee, Steffanie A ^b,c   Pu, Minya ^c   Havens, Jennifer R ^d   Cornelius, Llewellyn J ^e   Huettner, Steven ^b   Latkin, Carl A ^b  

^a TEMPLE UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; OPIATE AGONIST;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OPIATE ADDICTION; PSYCHOTHERAPY; RISK ASSESSMENT; SOCIAL NETWORK; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; MALE; METHADONE; NARCOTIC ANTAGONISTS; NEEDLE-EXCHANGE PROGRAMS; QUESTIONNAIRES; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 51149105500     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490802268165     Document Type: Article

References (48)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies; July 2007. The NSDUH Report: Demographic and Geographic Variations in Injection Drug Use. Rockville, MD.
2. Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction. 1998;93:73-92.
3. Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug Alcohol Depend. 2001;65:65-75.
4. Booth RE, Corsi KF, Mikulich SK. Improving entry into methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat. 2003;24:305-311.
5. Lloyd JJ, Ricketts EP, Strathdee SA, et al. Social contextual factors associated with entry into opiate agonist treatment among injection drug users. Am J Drug Alcohol Abuse. 2005;3:555-570.
6. Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction 1998;93:73-92.
7. Goehl L, Nunes E, Quitkin F, Hilton I. Social networks and methadone treatment outcome: The costs and benefits of societies. Am J Drug Alcohol Abuse. 1993;19:251-262.
8. Gogineni A, Stein MD, Friedmann PD. Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001;64:47-53.
9. Tuten M, Jones HE. A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend. 2003;70:327-330.
10. Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug Alcohol Depend. 2001;65:65-75.
11. Zapka JG, Stoddard AM, McCusker J. Social network, support and influence: Relationships with drug use and protective AIDS behavior. AIDS Educ Prev. 1993;5:352-566.
12. Willems JC, Iguchi MY, Lidz V, Bux DA. Change in drug-using networks of injecting drug users during methadone treatment: A pilot study using snowball recruitment and intensive interviews. Subst Use Misuse. 1997;32:1539-1554.
13. Cornelius LJ, Lloyd JJ, Bishai D, et al. The treatment retention intervention: A case study of an evaluation of a case management intervention to improve treatment outcomes for injection drug users. J Assoc Acad Minor Phys. 2006;17:44-53.
14. Rapp RC, Siegal HA, Fisher JH. A strengths-based model of case management/advocacy: Adapting a mental health model to practice work with persons who have substance abuse problems. NIDA Res Monogr. 1992;127:79-91.
15. Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug Alcohol Depend. 2006;83:225-232.
16. Rapp RC, Siegal HA, Li L, Saha P. Predicting postprimary treatment services and drug use outcome: A multivariate analysis. Am J Drug Alcohol Abuse. 1998;24:603-615.
17. Siegal HA, Fisher JH, Rapp RC, et al. Enhancing substance abuse treatment with case management. Its impact on employment. J Subst Abuse Treat. 1996;13:93-98.
18. Siegal HA, Li L, Rapp RC. Case management as a therapeutic enhancement: Impact on post-treatment criminality. J Addict Dis. 2002;21:37-46.
19. Mardsen PV. Network data and measurement. Annu Rev Sociol. 1990;16:435-463.
20. McNeely C, Falci C. School connectedness and the transition into and out of health-risk behavior among adolescents: A comparison of social belonging and teacher support. J Sch Health. 2004;74:284-292.
21. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. State Methadone Treatment Guidelines. Treatment Improvement Protocol (TIP) Series, Number 1. DHHS Pub. No. (SMA) 93-1991. Washington, DC: U.S. Government Printing Office; 1993.
22. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199-213.
23. Friedman SR, Jose B, Deren S, Des Jarlais D, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National Aids Research Consortium. Am J Epidemiol. 1995;142:864-874.
24. Latkin CA, Mandell W, Oziemkowska M, Vlahov D, Celentano DA. The relationships between sexual behavior, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland. Sex Transm Dis. 1994;21:161-167.
25. Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among newdrug injectors. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:499-509.
26. Needle RH, Coyle S, Cesari H, et al. HIV risk behaviors associated with the injection process: Multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse. 1998;33:2403-2423.
27. Suh T, Mandell W, Latkin CA. Social network characteristics of injecting HIV-risk behaviors among street injection drug users. Drug Alcohol Depend. 1997;47:37-43.
28. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer Verlag; 1991.
29. Institute of Medicine. Treating Drug Problems, Volume 1: A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems. Washington, DC: National Academy Press; 1990.
30. Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among intravenous drug users in-and out of treatment: An 18 month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6:1049-1056.
31. Yancovitz SR, Des Jarlais DC, Peyser NP, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991;81:1185-1191.
32. Johnson RA, Gerstein DR, Pach A III, Cerbone FG, Brown J. HIV risk behaviors in African-American drug injector networks: Implications of injection-partner mixing and partnership characteristics. Addiction. 2002;97:1011-1024.
33. Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: A focus on gender. Subst Use Misuse. 2001;36:2113-2136.
34. Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction. 2006;101:1003-1013.
35. Lakon CM, Ennett ST, Norton EC. Mechanisms through which drug, sex partner, and friendship network characteristics relate to risky needle use among high risk youth and young adults. Soc Sci Med. 2006;63:2489-2499.
36. Latkin CA, Mandell W, Oziemkowska M, et al. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995;38:1-9.
37. Unger JB, Kipke MD, De Rosa CJ, Hyde J, Ritt-Olson A, Montgomery S. Needle-sharing among young IV drug users and their social network members: The influence of the injection partner's characteristics on HIV risk behavior. Addict Behav. 2006;31:1607-1618.
38. Matos TD, Robles RR, Sahai H, et al. HIV risk behaviors and alcohol intoxication among injection drug users in Puerto Rico. Drug Alcohol Depend. 2004;76:229-234
39. Stein MD, Hanna L, Natarajan R, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat. 2000;8:359-363.
40. Bloor M. The Sociology of HIV Transmission. Thousand Oaks, Calif.: Sage Publications; 1995.
41. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38:67-78.
42. Valente TW, Vlahov D. Selective risk taking among needle exchange participants: Implications for supplemental interventions. Am J Public Health. 2001;91:406-411.
43. Barrera MA. A method for assessing social support networks in community survey research. Connections. 1980;3:8-13.
44. Broome KM, Simpson DD, Joe GW. The role of social support following short-term inpatient treatment. Am J Addict. 2002;11:57-65.
45. Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS. Recovery from opioid addiction in DATOS. J Subst Abuse Treat. 2003;25:177-186.
46. Latkin C, Mandell W, Vlahov D, Knowlton A, Oziemkowska M, Celentano D. Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance. Social Networks. 1995;17:219-228.
47. Tobin KE, Hua W, Costenbader EC, Latkin CA. The association between change in social network characteristics and non-fatal overdose: Results from the SHIELD study in Baltimore, MD, USA. Drug Alcohol Depend. 2007;87:63-68.
48. Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol. 1997;46:41-51.